Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia: Brain Health Support Program Intervention

NCT05347966 is registered in ClinicalTrials.gov with Baycrest as lead sponsor.

NCT NCT05347966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05347966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia: Brain Health Support Program Intervention
Lead sponsor
Baycrest
Phase
Not applicable
Overall status
Completed
Start date
April 6, 2022
Completion date
April 19, 2024
Enrollment
354 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive change, dementia prevention, mild cognitive impairment, subjective cognitive impairment